Navigation Links
Varian Medical Systems to Showcase Advanced Technologies for Treating Cancer with Image-Guided Radiotherapy and Radiosurgery at JASTRO Meeting in Tokyo, Japan
Date:11/20/2012

TOKYO, Nov. 20, 2012 /PRNewswire/ -- Varian Medical Systems, Inc. (NYSE: VAR), the leading manufacturer of medical devices for treating cancer, will exhibit the company's advanced technologies for image-guided radiotherapy and radiosurgery at the 25th Annual Meeting of the Japanese Society for Therapeutic Radiology and Oncology (JASTRO) here later this week.  During the meeting, Varian will also sponsor a luncheon seminar on the latest developments in stereotactic radiosurgery and stereotactic body radiotherapy—quick and non-invasive procedures that use high-energy X-rays to treat tumors in the brain or body.

Varian's booth at the meeting will showcase the company's latest products, including the TrueBeam™ medical linear accelerator for image-guided radiotherapy and radiosurgery, offering the high dose delivery rates, precision, and speed needed for precise radiosurgery and stereotactic body radiotherapy procedures.Varian personnel will also be on hand to demonstrate the latest releases of the ARIA® oncology information and Eclipse™ treatment planning software systems.  ARIA is a comprehensive information management solution that streamlines clinical processes, improves workflow, eliminates paper charts, and automates many aspects of managing complex cancer treatments.

"ARIA 11—the latest release—has been designed so that clinicians can personalize their home screen to easily access what they need, at the appropriate level of detail," said Makoto Yamada, sales manager for Varian in Japan.  "ARIA is now also more tightly integrated with the Eclipse system, enabling users to access both applications from a single workspace.  Clinics can configure the system to guide personnel through their daily tasks, and can set up workflows to incorporate safety checks as another quality assurance measure."

Varian Symposium on Stereotactic RadiosurgeryVarian will also sponsor a luncheon symposium on November 24, on the topic of stereotactic radiosurgery and stereotactic body radiotherapy (SBRT).  These quick and non-invasive procedures use carefully shaped high-energy X-ray beams to treat tumors in the brain or body.  Benjamin Slotman, MD, PhD, professor and chairman of the Department of Radiation Oncology at VU University Medical Center in Amsterdam, the Netherlands, will detail his clinical experience treating patients with these approaches, using Varian's TrueBeam™ system and its High Intensity Mode for delivering very high doses with precision and speed.

Dr. Slotman is an international expert in the field of stereotactic irradiation, the treatment of small cell lung cancer, and the early clinical implementation of new technologies.  He has co-authored more than 200 peer reviewed publications, many on the treatment of non-small cell lung cancer using stereotactic approaches.[1]  Dr. Slotman is currently serving as principal investigator of a multicenter randomized trial on the role of thoracic irradiation in lung cancer patients.  He is also the associate editor of the Journal of Radiosurgery and SBRT.

The symposium will be chaired by Hiroki Shirato, M.D., Ph.D., professor and chairman of the Department of Radiation Medicine at the Hokkaido University Graduate School of Medicine.  Dr. Shirato is an internationally-known expert in the management of tumor motion, a very important aspect of treating cancer with stereotactic body radiotherapy, since tumors in the body often move during treatment due to respiration or other normal physiological processes.

[1] Some representative publications:

  • Slotman BJ, Senan S. Radiotherapy in small---cell lung cancer: lessons learned and future directions. Int J Radiat Oncol Biol Phys 79, 998---1003, 2011.
  • Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):348-53.
  • Senthi S, Lagerwaard FJ, Haasbeek CJ, Slotman BJ, Senan S. Patterns of disease recurrence after stereotactic ablative radiotherapy for early stage non---small---cell lung cancer: a retrospective analysis. Lancet Oncol. 2012 Jun 21. [Epub ahead of print]
  • About Varian Medical Systems
    Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,100 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.FOR INFORMATION CONTACT:UNITED STATES

    JAPANMeryl Ginsberg

    Yayoi Shimizu Tel: +1.650.424.6444

    Tel: +81-3-4486-5010meryl.ginsberg@varian.com

    yayoi.shimizu@varian.com


    '/>"/>
    SOURCE Varian Medical Systems, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    2. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
    3. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
    4. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
    5. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
    6. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
    7. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
    8. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2012
    9. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
    10. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
    11. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of Stock through Calendar Year 2013
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/23/2016)... , June 23, 2016 The vast majority ... outpatient dialysis facility.  Treatments are usually 3 times a ... per visit, including travel time, equipment preparation and wait ... but especially grueling for patients who are elderly and ... skilled nursing and rehabilitation centers for some duration of ...
    (Date:6/23/2016)... FRANKLIN, Tenn. , June 23, 2016 ... for automating, integrating and transforming the patient ... launch of several innovative new products and ... depth of its revenue cycle offerings. These ... establish more efficient workflows, remain compliant in ...
    (Date:6/23/2016)... 2016  The National Pharmaceutical Council (NPC) today ... policy research organization as its newest member.  ... vice president and chief scientific officer, Mallinckrodt Pharmaceuticals, ... NPC Board of Directors. ... joined us in support of our efforts to ...
    Breaking Medicine Technology:
    (Date:6/26/2016)... ... ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a weight ... app plans to fix the two major problems leading the fitness industry today:, ... program , They don’t eliminate all the reasons people quit their exercise program ...
    (Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
    (Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
    (Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
    (Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
    Breaking Medicine News(10 mins):